Skip to NavigationSkip to content

Pharmafile - Sales and Marketing

The European Commission has chosen to expand the authorised indication for Amgen’s Blincyto (blinatumomab) in the region, it has emerged, approving...
Samsung Bioepis’ has announced that the FDA has chosen to approve Ontruzant (trastuzumab-dttb), its biosimilar version of Roche’s Herceptin (...
The European Commission has decided to approve a label extension in the region for Orkambi in the treatment of cystic fibrosis (CF), expanding the...
Clinical trials have led to nearly 5,000 deaths in India since 2005, while just a fraction of those affected have received compensation.

Features

Mesothelioma.net reviews the wide array of latest advances in treatment and care for patients affected by the challenging cancer as we slowly...

Appointments

ImmunSYS, a Fort Lauderdale, Florida-based firm focused on the development of innovative cancer immunotherapy products, today announced that...

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches